The regulation of gene editing techniques involving human cells in Taiwan was set up by the Ministry of Health and Welfare (MoHW). It is divided into two major categories including “gene therapy” and “human cell therapy”. In the process of developing human cell therapy, research involving human embryos and embryonic stem cells was firstly regulated by ethic guidelines announced by the MoHW. According to Walters’ national regulatory models on Human Embryonic Stem Cell Research in 2008, Taiwan belongs to “the Moderate Option”, which is between “restrictive” and “permissive” policy options that allows deriving human embryo stem cell lines only from spared embryos left over from the fertility/IVF clinics.


  1. Chen-Shan Li (1995) From the perspective of the constitution protection the right to life and human dignity to discuss artificial reproduction. Taiwan Law Rev 2:18–25Google Scholar
  2. Chen-Shan Li (2000) Human dignity and protection of human rights, 1st edn. Angle, Taiwan, pp 89–92Google Scholar
  3. Daniel Fu-Chang Tsai (2004) Debates on moral issues of human stem cell research II. Health World 220:44–46Google Scholar
  4. Fong Chun Huang, Ywan Feng Li (2014) Current status and developmental considerations of stem cell therapy products in Taiwan. Reg Med News 49:22–31Google Scholar
  5. Jen-Ji Ho (1999) Comments on ministry of justice seminar on human cloning issues. Newsl Biotechnol Law 1:5–6Google Scholar
  6. Walters L (2008) An intercultural perspective on human embryonic stem cell research. In: Østnor L (ed) Stem cells, human embryos and ethics. Springer, Holland, pp 92–93CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2020

Authors and Affiliations

  1. 1.Research Institute of Medical Education & BioethicsNational Taiwan University College of MedicineTaipeiTaiwan

Personalised recommendations